Minakem Generic APIs Minakem Generic APIs

X

Find the latest Drugs in Development and Pipeline Prospector News of Journey Colab.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Journey Colab
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
San Francisco, California
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

The funding will be used to accelerate the development of Journey Colab’s portfolio of psychedelic compounds. Journey Colab’s lead compound, Mescaline HCl (JOUR-001), is being developed for the treatment of Alcohol Use Disorder (AUD).


Lead Product(s): Mescaline

Therapeutic Area: Psychiatry/Psychology Product Name: JOUR-001

Highest Development Status: PreclinicalProduct Type: Small molecule

Partner/Sponsor/Collaborator: MBX Capital

Deal Size: $12.0 million Upfront Cash: Undisclosed

Deal Type: Series A Financing September 07, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY